Connect Biopharma Executives Transition to New Roles

TipRanksAug 2 17:27 ET

Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum

Connect Biopharma Jul 1 00:00 ET

ADRs Advance; Connect Biopharma Holdings Climbs 19%

Dow JonesJun 28 16:50 ET

Kangnai De Life Science (CNTB.US) is trapped on the eve of commercialization: the founder left and the stock price fell more than 30% in seven days.

On June 21st, the stock price of Kangnaide Biotechnology (CNTB.US) fell by 3.95%. This is the seventh trading day since its Chinese founding team completely left the company, and also the seventh trading day of the company's new round of stock price decline. During this period, the company's stock price has accumulated a 31.86% decline.

Zhitong FinanceJun 23 07:23 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaJun 13 08:07 ET

Connect Biopharma Hldgs Analyst Ratings

BenzingaJun 13 06:35 ET